Read news on Retinitis Pigmentosa with our app.
Read more in the app
Kiora’s phase 1 ABACUS study of KIO-301 in retinitis pigmentosa published in Nature Medicine; phase 2 trial underway - EurekAlert!
Nanobody may lead to treatment for Retinitis Pigmentosa
